4
Changes in Ownership
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Filed Acc 0001127602-21-008729
Corporate Executive VP & CFO sold 4,366 shares at $290.12 ($1,266,647)
- Corporate Executive VP & CFO acquired 4,366 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Smith David Ross Corporate Executive VP & CFO | 2021-03-01 | Option exercise | +4,366 | $88.05 | $384,426 | 21,228 | D |
| Smith David Ross Corporate Executive VP & CFO | 2021-03-01 | Sale | −4,366 | $290.12 | $1,266,647 | 16,862 | D |
| Derivatives | |||||||
| Smith David Ross Corporate Executive VP & CFO | 2021-03-01 | Option exercise · Stock Options (Right to Buy) | −4,366 | 0 | D | ||
| Open-market sales · 4,366 sh · avg $290.12 · $1,266,647 | |||||||
Loading xslF345X03/form4.xml…